Keystone shows Gates the money

In our May issue, James Aiken, the CEO of the Keystone Symposia, linkurl:wrote that;http://www.the-scientist.com/article/display/23399/ ?the long reach of Bill Gates? had ?finally touched the Keystone Symposia, and all of conference planning, really.? Aiken was writing a grant proposal to the Foundation, and they required him to show measured value for the conferences. Aiken went on to describe a method for quantifying the conferences? impact. When he tallied the results of the instrument Keys

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
In our May issue, James Aiken, the CEO of the Keystone Symposia, linkurl:wrote that;http://www.the-scientist.com/article/display/23399/ ?the long reach of Bill Gates? had ?finally touched the Keystone Symposia, and all of conference planning, really.? Aiken was writing a grant proposal to the Foundation, and they required him to show measured value for the conferences. Aiken went on to describe a method for quantifying the conferences? impact. When he tallied the results of the instrument Keystone used, the results were impressive: ?Conservative extrapolation to the entire Keystone Symposia season of meetings would suggest that at least $20 to $30 million in research funds is diverted to more effective use each year because of information learned at our conferences,? Aiken wrote. Those results seem to have impressed the Gates Foundation, too, which just linkurl:gave Keystone a $2.6 million grant;http://www.keystonesymposia.org/News/ to expand its Global Health Series. According to the Foundation, the survey results were one of the key factors in the foundation's decision to continue supporting Keystone. For tips on how to apply to non-profits for grants to support your own research, keep an eye out for our November issue.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Ivan Oransky

    This person does not yet have a bio.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio